HealthStream
HSTM Small CapHealthcare · Health Information Services
Mis à jour: Aug 2, 2026, 22:14 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
HealthStream en bref
HealthStream (HSTM) is currently trading at 24,31 € with a market capitalization of 710 M €. The trailing P/E ratio stands at 41.85x, with a forward P/E of 32.42x. The 52-week range spans from 16,91 € to 26,01 €; the current price is 6.5% below the yearly high. Year-over-year revenue growth stands at +10.5%. The net profit margin stands at 6.39%.
💰 Dividende
HealthStream pays an annual dividend of 0,11 € per share, representing a yield of 0.46%. The payout ratio stands at 19.1%.
📊 Avis des analystes
2 analystes évaluent HealthStream (HSTM) au consensus : Acheter. L'objectif de cours moyen est de 29,04 €, soit un potentiel de +19.47% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 23,41 € à 34,68 €.
HealthStream : la thèse d'investissement en détail
HealthStream (HSTM) operates in the Healthcare — specifically Health Information Services — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
Revenue is growing at a healthy 10.5% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 42.9% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. With a gross margin near 64.89%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.
Le scénario baissier
Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.
Valorisation en contexte
At a PEG of 3.27, investors are paying more than three times the growth rate for each unit of earnings — that pricing assumes growth not only continues but accelerates from here.
À surveiller
- The forward P/E of 32.42x is meaningfully below the trailing 41.85x — analysts expect earnings to step up; the next earnings release is the test.
Thèse d'investissement : forces et faiblesses
- Marge brute élevée de 64.89% — signe d'un pouvoir de fixation des prix
- Consensus des analystes : Buy
- Bilan solide avec faible endettement (D/E 4)
- Free cash flow positif
- –Actuellement jugée surévaluée
Aperçu technique
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Profil de risque
The data points to relatively defensive market behavior, elevated short interest (5.9%).
Trading Data
💵 Dividend Info
Related Stocks in the Same Sector
More Santé stocks
Top peers in the same sector — ranked by market cap.
Where can I buy HealthStream?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
📊 Plutôt un fonds qu’une action isolée ? Comparatif d’ETF :
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news